These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 25162674)

  • 1. Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.
    Comar M; Zanotta N; Bonotti A; Tognon M; Negro C; Cristaudo A; Bovenzi M
    PLoS One; 2014; 9(8):e104848. PubMed ID: 25162674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
    Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
    Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
    Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
    Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation.
    Nuvoli B; Sacconi A; Bottillo G; Sciarra F; Libener R; Maconi A; Carosi M; Piperno G; Mastropasqua E; Papale M; Camera E; Galati R
    Biomed Pharmacother; 2024 Jun; 175():116662. PubMed ID: 38692064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
    Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma.
    Comar M; Rizzardi C; de Zotti R; Melato M; Bovenzi M; Butel JS; Campello C
    Cancer Res; 2007 Sep; 67(18):8456-9. PubMed ID: 17875683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.
    Xu J; Alexander DB; Iigo M; Hamano H; Takahashi S; Yokoyama T; Kato M; Usami I; Tokuyama T; Tsutsumi M; Tamura M; Oguri T; Niimi A; Hayashi Y; Yokoyama Y; Tonegawa K; Fukamachi K; Futakuchi M; Sakai Y; Suzui M; Kamijima M; Hisanaga N; Omori T; Nakae D; Hirose A; Kanno J; Tsuda H
    Cancer Sci; 2015 Jul; 106(7):825-32. PubMed ID: 25940505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.
    Felten MK; Khatab K; Knoll L; Schettgen T; Müller-Berndorff H; Kraus T
    Int Arch Occup Environ Health; 2014 Feb; 87(2):195-204. PubMed ID: 23423281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy.
    Comar M; Zanotta N; Pesel G; Visconti P; Maestri I; Rinaldi R; Crovella S; Cortale M; De Zotti R; Bovenzi M
    Tumori; 2012; 98(2):210-4. PubMed ID: 22677986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.
    Johnen G; Burek K; Raiko I; Wichert K; Pesch B; Weber DG; Lehnert M; Casjens S; Hagemeyer O; Taeger D; Brüning T;
    Sci Rep; 2018 Sep; 8(1):14321. PubMed ID: 30254313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Not Available].
    Barbieri PG; Sommigliana AB
    Med Lav; 2016 Jul; 107(4):315-26. PubMed ID: 27464904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular epidemiology case control study on pleural malignant mesothelioma.
    Bolognesi C; Martini F; Tognon M; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Ivaldi GP; Betta P; Mutti L; Puntoni R
    Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1741-6. PubMed ID: 16030111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma.
    Duong BTV; Wu L; Green BJ; Bavaghar-Zaeimi F; Wang Z; Labib M; Zhou Y; Cantu FJP; Jeganathan T; Popescu S; Pantea J; de Perrot M; Kelley SO
    EBioMedicine; 2020 Nov; 61():103031. PubMed ID: 33045471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts.
    Alchami FS; Attanoos RL; Gibbs A; Morgan F; Jasani B
    Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):444-447. PubMed ID: 31205069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
    Filiberti R; Marroni P; Spigno F; Merlo DF; Mortara V; Caruso P; Cioè A; Michelazzi L; Bruzzone A; Bobbio B; Simonassi C; Del Corso L; Galli R; Racchi O; Dini G; Linares R; Mencoboni M
    Oncology; 2014; 86(1):33-43. PubMed ID: 24401539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.
    Bayram M; Dongel I; Akbaş A; Benli I; Akkoyunlu ME; Bakan ND
    Lung; 2014 Feb; 192(1):197-203. PubMed ID: 24170217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
    Santarelli L; Staffolani S; Strafella E; Nocchi L; Manzella N; Grossi P; Bracci M; Pignotti E; Alleva R; Borghi B; Pompili C; Sabbatini A; Rubini C; Zuccatosta L; Bichisecchi E; Valentino M; Horwood K; Comar M; Bovenzi M; Dong LF; Neuzil J; Amati M; Tomasetti M
    Lung Cancer; 2015 Dec; 90(3):457-64. PubMed ID: 26431916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.
    Cristaudo A; Foddis R; Vivaldi A; Buselli R; Gattini V; Guglielmi G; Cosentino F; Ottenga F; Ciancia E; Libener R; Filiberti R; Neri M; Betta P; Tognon M; Mutti L; Puntoni R
    Cancer Res; 2005 Apr; 65(8):3049-52. PubMed ID: 15833832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.
    De Santi C; Pucci P; Bonotti A; Melaiu O; Cipollini M; Silvestri R; Vymetalkova V; Barone E; Paolicchi E; Corrado A; Lepori I; Dell'Anno I; Pellè L; Vodicka P; Mutti L; Foddis R; Cristaudo A; Gemignani F; Landi S
    Occup Environ Med; 2017 Jun; 74(6):456-463. PubMed ID: 28343162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.